老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Can-Fite Biopharma Ltd

1.20
-0.0300-2.44%
盤後：1.200.00000.00%19:53 EDT
成交量：34.95萬
成交額：42.70萬
市值：1,542.37萬
市盈率：-1.10
高：1.27
開：1.27
低：1.18
收：1.23
資料載入中...
總覽公司新聞公告
2021/03/25

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/30

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/10/07

SEC問詢函

CORRESP [Cover] - Correspondence
2020/08/27

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/07/22

SEC問詢函

CORRESP [Cover] - Correspondence
2020/07/10

招股説明書

F-1 - Registration statement for certain foreign private issuers
2020/06/19

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/19

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/01

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/06

SEC問詢函

CORRESP [Cover] - Correspondence
2020/04/06

SEC問詢函

CORRESP [Cover] - Correspondence
2020/04/02

非美公司披露報告

6-K/A [Amend] - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/27

招股説明書

F-1 - Registration statement for certain foreign private issuers
更多